Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 15 | 2019 | 37 | 3.050 |
Why?
|
| Brain | 24 | 2021 | 1649 | 1.940 |
Why?
|
| Brain Injuries | 7 | 2019 | 33 | 1.850 |
Why?
|
| Alzheimer Disease | 15 | 2023 | 2109 | 1.780 |
Why?
|
| TDP-43 Proteinopathies | 6 | 2023 | 112 | 1.740 |
Why?
|
| Aging | 17 | 2023 | 1544 | 1.620 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2023 | 22 | 1.620 |
Why?
|
| Lewy Bodies | 8 | 2023 | 192 | 1.560 |
Why?
|
| Frontotemporal Lobar Degeneration | 3 | 2023 | 29 | 1.550 |
Why?
|
| DNA-Binding Proteins | 8 | 2023 | 276 | 1.440 |
Why?
|
| Olfaction Disorders | 2 | 2021 | 49 | 1.330 |
Why?
|
| Frontotemporal Dementia | 3 | 2023 | 13 | 1.100 |
Why?
|
| Aged, 80 and over | 31 | 2023 | 4777 | 1.020 |
Why?
|
| Cerebral Cortex | 5 | 2021 | 155 | 1.010 |
Why?
|
| Angiopoietin-1 | 6 | 2016 | 6 | 0.990 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2019 | 75 | 0.980 |
Why?
|
| Lewy Body Disease | 3 | 2021 | 97 | 0.920 |
Why?
|
| Male | 44 | 2023 | 14772 | 0.870 |
Why?
|
| Rats | 15 | 2019 | 664 | 0.860 |
Why?
|
| Animals | 22 | 2019 | 3642 | 0.850 |
Why?
|
| Brain Edema | 5 | 2011 | 15 | 0.800 |
Why?
|
| Substantia Nigra | 3 | 2021 | 120 | 0.800 |
Why?
|
| Parkinsonian Disorders | 6 | 2023 | 225 | 0.790 |
Why?
|
| Cognitive Dysfunction | 5 | 2023 | 1061 | 0.790 |
Why?
|
| Dementia | 5 | 2019 | 560 | 0.790 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 125 | 0.750 |
Why?
|
| Humans | 56 | 2023 | 27072 | 0.740 |
Why?
|
| Amygdala | 1 | 2021 | 39 | 0.720 |
Why?
|
| Endothelium, Vascular | 8 | 2005 | 45 | 0.720 |
Why?
|
| Olfactory Bulb | 2 | 2023 | 17 | 0.700 |
Why?
|
| Temporal Lobe | 2 | 2018 | 83 | 0.680 |
Why?
|
| Neocortex | 1 | 2019 | 31 | 0.650 |
Why?
|
| Female | 38 | 2023 | 15212 | 0.630 |
Why?
|
| Immunohistochemistry | 7 | 2017 | 366 | 0.610 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 1368 | 0.600 |
Why?
|
| Angiopoietin-2 | 4 | 2005 | 4 | 0.600 |
Why?
|
| Caveolin 1 | 4 | 2016 | 10 | 0.570 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 16 | 0.560 |
Why?
|
| Proteins | 2 | 2011 | 65 | 0.550 |
Why?
|
| Cognition | 7 | 2021 | 1339 | 0.540 |
Why?
|
| Rats, Wistar | 8 | 2019 | 51 | 0.540 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 51 | 0.500 |
Why?
|
| Memory Disorders | 1 | 2017 | 159 | 0.490 |
Why?
|
| Cerebral Ventricle Neoplasms | 2 | 2013 | 7 | 0.490 |
Why?
|
| Glioma, Subependymal | 2 | 2013 | 6 | 0.480 |
Why?
|
| Neovascularization, Pathologic | 4 | 2005 | 37 | 0.480 |
Why?
|
| Tight Junctions | 4 | 2011 | 18 | 0.480 |
Why?
|
| Aged | 22 | 2023 | 8997 | 0.450 |
Why?
|
| Spinal Cord | 4 | 2018 | 84 | 0.450 |
Why?
|
| Ependymoma | 1 | 2013 | 18 | 0.420 |
Why?
|
| Endothelial Cells | 2 | 2011 | 59 | 0.410 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 111 | 0.410 |
Why?
|
| Blood Vessels | 2 | 2011 | 14 | 0.410 |
Why?
|
| Hippocampus | 1 | 2015 | 273 | 0.410 |
Why?
|
| Parkinson Disease | 5 | 2023 | 670 | 0.400 |
Why?
|
| Brain Diseases | 4 | 2021 | 66 | 0.390 |
Why?
|
| Cold Temperature | 4 | 2008 | 28 | 0.390 |
Why?
|
| Fibronectins | 5 | 2019 | 19 | 0.390 |
Why?
|
| Autopsy | 5 | 2021 | 344 | 0.380 |
Why?
|
| Arteriolosclerosis | 3 | 2023 | 78 | 0.370 |
Why?
|
| Neuropsychological Tests | 7 | 2023 | 1196 | 0.370 |
Why?
|
| Cell Adhesion Molecules | 2 | 2008 | 21 | 0.350 |
Why?
|
| Neurons | 5 | 2013 | 339 | 0.350 |
Why?
|
| RNA, Messenger | 4 | 2005 | 310 | 0.330 |
Why?
|
| Membrane Proteins | 2 | 2008 | 165 | 0.330 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 879 | 0.320 |
Why?
|
| Cognition Disorders | 5 | 2018 | 985 | 0.320 |
Why?
|
| Disease Progression | 5 | 2019 | 673 | 0.320 |
Why?
|
| Astrocytes | 1 | 2011 | 144 | 0.320 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 271 | 0.310 |
Why?
|
| Microscopy, Electron | 3 | 2003 | 65 | 0.310 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2007 | 7 | 0.290 |
Why?
|
| Mycosis Fungoides | 1 | 2007 | 6 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 1112 | 0.290 |
Why?
|
| Horseradish Peroxidase | 4 | 2016 | 4 | 0.290 |
Why?
|
| Muscular Diseases | 1 | 2007 | 13 | 0.290 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2007 | 28 | 0.290 |
Why?
|
| Occludin | 3 | 2016 | 8 | 0.280 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2020 | 34 | 0.270 |
Why?
|
| Cerebrovascular Disorders | 2 | 2023 | 133 | 0.270 |
Why?
|
| Depression | 3 | 2016 | 444 | 0.260 |
Why?
|
| Angiopoietins | 3 | 2011 | 15 | 0.260 |
Why?
|
| Endothelial Growth Factors | 2 | 2002 | 11 | 0.250 |
Why?
|
| Apoptosis | 2 | 2007 | 213 | 0.240 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2005 | 1 | 0.240 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2005 | 2 | 0.240 |
Why?
|
| Locus Coeruleus | 3 | 2013 | 21 | 0.230 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 599 | 0.230 |
Why?
|
| Adult | 9 | 2023 | 7831 | 0.230 |
Why?
|
| Plaque, Amyloid | 2 | 2015 | 145 | 0.220 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 4 | 0.210 |
Why?
|
| Caveolae | 3 | 2011 | 17 | 0.210 |
Why?
|
| Limbic Encephalitis | 1 | 2023 | 13 | 0.210 |
Why?
|
| Independent Living | 3 | 2023 | 322 | 0.210 |
Why?
|
| Motor Disorders | 1 | 2023 | 23 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 25 | 0.210 |
Why?
|
| Neurofibrillary Tangles | 4 | 2023 | 193 | 0.210 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 68 | 0.210 |
Why?
|
| Histocytochemistry | 1 | 2003 | 14 | 0.210 |
Why?
|
| Cerebrum | 1 | 2023 | 9 | 0.200 |
Why?
|
| Cohort Studies | 6 | 2018 | 1890 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2023 | 53 | 0.200 |
Why?
|
| Meningitis | 1 | 2022 | 10 | 0.200 |
Why?
|
| Telencephalon | 1 | 2002 | 1 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 324 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2016 | 443 | 0.180 |
Why?
|
| Logistic Models | 3 | 2017 | 395 | 0.180 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 2 | 0.180 |
Why?
|
| Late Onset Disorders | 1 | 2020 | 6 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 11 | 0.170 |
Why?
|
| Rats, Inbred WF | 3 | 2005 | 6 | 0.170 |
Why?
|
| Illinois | 1 | 2020 | 250 | 0.160 |
Why?
|
| Coloring Agents | 2 | 2013 | 14 | 0.160 |
Why?
|
| Capillary Permeability | 3 | 2003 | 29 | 0.160 |
Why?
|
| Headache | 2 | 2017 | 35 | 0.160 |
Why?
|
| Motor Neurons | 1 | 2018 | 18 | 0.150 |
Why?
|
| Comorbidity | 1 | 2020 | 481 | 0.150 |
Why?
|
| Middle Aged | 9 | 2019 | 8923 | 0.150 |
Why?
|
| Movement | 1 | 2018 | 112 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 88 | 0.150 |
Why?
|
| Age Factors | 1 | 2020 | 766 | 0.140 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 3 | 0.140 |
Why?
|
| Facial Pain | 1 | 2017 | 6 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2018 | 75 | 0.140 |
Why?
|
| Microvessels | 1 | 2017 | 14 | 0.140 |
Why?
|
| Vision Disorders | 1 | 2017 | 20 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2016 | 149 | 0.140 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 188 | 0.140 |
Why?
|
| Linear Models | 1 | 2018 | 247 | 0.140 |
Why?
|
| Time Factors | 4 | 2013 | 1433 | 0.140 |
Why?
|
| Fluorescent Dyes | 2 | 2011 | 34 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2011 | 15 | 0.140 |
Why?
|
| Endothelium | 2 | 2011 | 14 | 0.140 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 15 | 0.140 |
Why?
|
| Hypertension | 3 | 2003 | 192 | 0.140 |
Why?
|
| Brain Stem | 2 | 2016 | 19 | 0.140 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 90 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor B | 2 | 2009 | 2 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 348 | 0.130 |
Why?
|
| Epidermal Cyst | 1 | 2016 | 5 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2016 | 43 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 57 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 137 | 0.120 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 6 | 0.120 |
Why?
|
| Choroid Plexus | 2 | 2007 | 7 | 0.120 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 14 | 0.120 |
Why?
|
| Visceral Afferents | 1 | 2015 | 4 | 0.120 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2015 | 8 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 100 | 0.120 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 23 | 0.120 |
Why?
|
| United States | 1 | 2021 | 2035 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 80 | 0.120 |
Why?
|
| Sclerosis | 1 | 2015 | 66 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2007 | 91 | 0.120 |
Why?
|
| Multiple System Atrophy | 1 | 2015 | 32 | 0.120 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 19 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 31 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2014 | 3 | 0.110 |
Why?
|
| gamma-Tocopherol | 1 | 2014 | 9 | 0.110 |
Why?
|
| alpha-Tocopherol | 1 | 2014 | 13 | 0.110 |
Why?
|
| Immunocompetence | 1 | 2013 | 6 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2013 | 9 | 0.110 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 7 | 0.110 |
Why?
|
| Quadriplegia | 1 | 2013 | 8 | 0.110 |
Why?
|
| Neuroma, Acoustic | 1 | 2013 | 10 | 0.110 |
Why?
|
| Mesencephalon | 1 | 2013 | 24 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 130 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2013 | 34 | 0.110 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 18 | 0.110 |
Why?
|
| Biomarkers | 2 | 2007 | 562 | 0.110 |
Why?
|
| Apolipoprotein E4 | 1 | 2015 | 263 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 11 | 0.100 |
Why?
|
| Inflammation | 3 | 2007 | 272 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 11 | 0.100 |
Why?
|
| Leiomyosarcoma | 1 | 2013 | 21 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 86 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2013 | 42 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1792 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 122 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2011 | 19 | 0.090 |
Why?
|
| Antibodies | 1 | 2011 | 46 | 0.090 |
Why?
|
| Synapses | 1 | 2011 | 36 | 0.090 |
Why?
|
| Aquaporin 1 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Aquaporin 4 | 1 | 2009 | 4 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 19 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2019 | 1778 | 0.080 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptor, TIE-2 | 2 | 2005 | 2 | 0.070 |
Why?
|
| Sural Nerve | 1 | 2007 | 4 | 0.070 |
Why?
|
| Neural Conduction | 1 | 2007 | 11 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2014 | 310 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 17 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 371 | 0.070 |
Why?
|
| Claudin-5 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Muscle Weakness | 1 | 2007 | 34 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 25 | 0.070 |
Why?
|
| Alleles | 2 | 2020 | 216 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 96 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2007 | 99 | 0.070 |
Why?
|
| Biopsy | 1 | 2007 | 201 | 0.070 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Skin | 1 | 2007 | 123 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2007 | 170 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 15 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 20 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 26 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 117 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 7 | 0.060 |
Why?
|
| Prognosis | 1 | 2007 | 785 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 383 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3485 | 0.060 |
Why?
|
| Memory | 2 | 2018 | 297 | 0.060 |
Why?
|
| Myocardium | 1 | 2004 | 101 | 0.060 |
Why?
|
| Gene Expression | 1 | 2005 | 199 | 0.060 |
Why?
|
| Encephalitis | 1 | 2003 | 11 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 29 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 133 | 0.050 |
Why?
|
| Cell Count | 2 | 2013 | 81 | 0.050 |
Why?
|
| Microtomy | 1 | 2003 | 1 | 0.050 |
Why?
|
| Monosaccharides | 1 | 2003 | 1 | 0.050 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 2003 | 1 | 0.050 |
Why?
|
| Lanthanum | 1 | 2003 | 2 | 0.050 |
Why?
|
| Tissue Embedding | 1 | 2003 | 4 | 0.050 |
Why?
|
| Pia Mater | 1 | 2003 | 2 | 0.050 |
Why?
|
| CpG Islands | 1 | 2003 | 53 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 6 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 4 | 0.050 |
Why?
|
| Pericytes | 1 | 2003 | 7 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2003 | 16 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2003 | 14 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2003 | 15 | 0.050 |
Why?
|
| Peroxidases | 1 | 2003 | 7 | 0.050 |
Why?
|
| Antigens | 1 | 2003 | 11 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2003 | 18 | 0.050 |
Why?
|
| Capillaries | 1 | 2003 | 11 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2003 | 11 | 0.050 |
Why?
|
| Chemokines | 1 | 2003 | 21 | 0.050 |
Why?
|
| Cats | 1 | 2003 | 29 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 99 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2002 | 6 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 43 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 10 | 0.050 |
Why?
|
| Mitochondria | 1 | 2003 | 67 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 49 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 180 | 0.050 |
Why?
|
| Meninges | 1 | 2022 | 8 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 24 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 96 | 0.050 |
Why?
|
| Macrophages | 1 | 2003 | 102 | 0.050 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 383 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 10 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 80 | 0.050 |
Why?
|
| Mice | 2 | 2003 | 1395 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 112 | 0.050 |
Why?
|
| tau Proteins | 1 | 2023 | 232 | 0.050 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2014 | 7 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 322 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2020 | 45 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 115 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 125 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 641 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 126 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 1994 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2018 | 116 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3538 | 0.040 |
Why?
|
| Microglia | 1 | 2018 | 143 | 0.040 |
Why?
|
| Scalp | 1 | 2016 | 5 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 83 | 0.030 |
Why?
|
| Sacrum | 1 | 2015 | 24 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 100 | 0.030 |
Why?
|
| Cell Nucleus Shape | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 8 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 346 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 90 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 7 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 9 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2012 | 31 | 0.030 |
Why?
|
| Amyloid | 1 | 2012 | 56 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 564 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 642 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 260 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2013 | 281 | 0.020 |
Why?
|
| CD59 Antigens | 1 | 2007 | 2 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2007 | 2 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 12 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 7 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 31 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 50 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 67 | 0.020 |
Why?
|
| Necrosis | 1 | 2005 | 26 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 189 | 0.020 |
Why?
|
| Craniotomy | 1 | 2005 | 22 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2004 | 23 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 147 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 332 | 0.010 |
Why?
|
| Gene Library | 1 | 2003 | 8 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 25 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 43 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 37 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 77 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 169 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 336 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 520 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 415 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 2172 | 0.010 |
Why?
|